Y3R-61851-96452

3 vaccinations 26 coded responses 33 check-ins 26 free-text entries 7 call cases

Sex: Female
Age at first dose: 36-40
ZIP prefix: 220 / VA
Registered: 2021-04-03

Relationship: Self
Race: Black or African American
Ethnicity: Not Hispanic or Latino

Registered dependents

8ZE-87970-12479 Child or adolescent in my care · Female · 2021-07-21

YCQ-83050-42077 Child or adolescent in my care · Female · 2021-11-13

P2E-83959-29648 Child or adolescent in my care · Male · 2021-11-13

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2260360 (opens in a new window)	high	11 / 11	—	2 of 3 VAERS symptoms	same dose (3)	VA matches	2022-01-25 / 2022-02-15 / 2022-05-02 received the same day as the last call	case 607591

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-03
Registered in v-safe
2021-04-04
Dose 1 — Pfizer-BioNTech
2021-04-04
Survey response — day 0, dose 1
MedDRA: Dizziness — Feeling: Fair

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-06
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness — Feeling: Fair · Headache, Muscle or body aches, Nausea, Diarrhea

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-07
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness — Feeling: Fair · Fever · Muscle or body aches, Fatigue or tiredness, Nausea

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-09
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness — Feeling: Fair · Fever · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-10
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness, Respiratory tract congestion — Feeling: Fair · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea

Free text: Dizziness and Congestion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-11
Survey response — day 7, dose 1
MedDRA: Dizziness — Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-18
Survey response — day 14, dose 1
MedDRA: Dizziness, Fatigue, Nausea — Feeling: Fair · Be unable to do your normal daily activities

Free text: Dizziness, nausea, and fatigue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-25
Dose 2 — Pfizer-BioNTech
2021-04-25
Survey response — day 0, dose 2
MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness, Nausea

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-26
Survey response — days 1–6 daily, dose 2
MedDRA: Confusional state, Dizziness — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work

Free text: Dizziness and confusion last night

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-27
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-28
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Fair · Site: Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-29
Survey response — days 1–6 daily, dose 2
MedDRA: Confusional state, Dizziness — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Free text: Dizziness, and confusion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-30
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-01
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-02
Survey response — day 7, dose 2
MedDRA: Decreased appetite, Dizziness, Menstrual disorder — Feeling: Poor · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Dizziness, change in menstrual cycle, and loss of appetite

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-02
Report sent to call center — day 7, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-09
Survey response — day 14, dose 2
MedDRA: Decreased appetite, Emergency care — Feeling: Poor · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Lack of appetite. Checked into the ER last Sunday.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-09
Report sent to call center — day 14, dose 2
Be unable to work · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-16
Survey response — day 21, dose 2
MedDRA: Decreased appetite, Dizziness, Weight decreased — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

Free text: Dizziness, loss of appetite, and weight loss

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-16
Report sent to call center — day 21, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-23
Survey response — day 28, dose 2
MedDRA: Decreased appetite, Weight decreased — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Rapid weight loss, and loss of appetite

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-23
Report sent to call center — day 28, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-30
Survey response — day 35, dose 2
MedDRA: Decreased appetite, Dizziness, Weight decreased — Feeling: Poor · Be unable to do your normal daily activities

Free text: Lack of appetite, weight loss, and dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-08
Survey response — day 42, dose 2
MedDRA: Decreased appetite, Menstruation irregular, Weight decreased — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Appetite loss, weight loss, menstrual changes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-08
Report sent to call center — day 42, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-27
Survey response — 3 months, dose 2
MedDRA: Chills, Migraine, Weight decreased — Feeling: Fair · Be unable to do your normal daily activities

Free text: Weight loss, migraines, and chills

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-09-04
Call 1 — Left Voicemail
2021-09-14
Call 2 — Left Voicemail
2021-09-14
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2021-10-24
Survey response — 6 months, dose 2
MedDRA: Dizziness, Dyspnoea, Fatigue, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Difficulty breathing, congestion, fever, dizzy, and fatigued

MedDRA releases: 2024-11 · check-in free text available
2021-10-24
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-10-29
Call 1 — Left Voicemail
2022-01-25
Dose 3 — Pfizer-BioNTech
2022-01-26
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-01-27
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Swelling · Fever · Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-01-29
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Rash, not including the immediate area around the injection site

Adult check-in
2022-01-31
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness

Adult check-in
2022-02-01
Health check-in — day 7, dose 3
Feeling: Good · Site: Pain · Fever · Nausea

Adult check-in
2022-02-08
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-02-15
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-02-22
Survey response — day 28, dose 3
MedDRA: Menstruation irregular — Feeling: Fair · Be unable to do your normal daily activities

Free text: Missed period

MedDRA releases: 2024-11 · check-in free text available
2022-03-01
Survey response — day 35, dose 3
MedDRA: Amenorrhoea — Feeling: Fair

Free text: A month and no menstrual cycle

MedDRA releases: 2024-11 · check-in free text available
2022-03-08
Survey response — day 42, dose 3
MedDRA: Menstruation irregular — Feeling: Fair · Be unable to do your normal daily activities

Free text: Cessation of menstrual cycle

MedDRA releases: 2024-11 · check-in free text available
2022-04-28
Survey response — 3 months, dose 3
MedDRA: Amenorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Cessation of my menstral cycle for 3.5 months.

MedDRA releases: 2024-11 · check-in free text available
2022-04-28
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-05-02
Call 1 — Left Voicemail
2022-05-02
Call successful
Completed over the phone

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-04	Pfizer-BioNTech
2	2021-04-25	Pfizer-BioNTech
3	2022-01-25	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-05-02	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-05-09	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-05-16	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-05-23	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-06-08	Successful 2021-09-14	Reported to VAERS voluntarily prior to GDIT contact
2021-10-24	Successful	Reported to VAERS voluntarily prior to GDIT contact
2022-04-28	Successful 2022-05-02	Completed over the phone